PMA
P980037: ANGIOJET RHEOLYTIC THROMBECTOMY LF140 CATHETER
FDA PMA · CATHETER, CORONARY, ATHERECTOMY · Boston Scientific Corp
Key facts
| PMA number | P980037 |
|---|---|
| Trade name | ANGIOJET RHEOLYTIC THROMBECTOMY LF140 CATHETER |
| Generic name | CATHETER, CORONARY, ATHERECTOMY |
| Applicant | Boston Scientific Corp |
| Owner/operator | Boston Scientific Corporation |
| Product code | MCX |
| Approval date | Mar 12, 1999 |
| Docket number | 99M-2015 |
| Notice date | Jun 28, 1999 |
| Establishment registration | 3005099803 |
| FEI number | 3005099803 |
At a glance
- 10–99 Supplements
- Aug 1, 2025 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- 10–99 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: